Federal right-to-try legislation passed in the Senate and now awaiting a vote in the House would only minimally benefit patient access to investigational drugs and would delay the FDA’s approval…
The fine was over Teva paying bribes to foreign officials to win business in Russia, Ukraine and Mexico, the ministry said. Source: BioSpace
Many investors and analysts expect that the changes to the corporate tax code will lead to increased merger and acquisition activity in 2018. Source: BioSpace
Corbin Therapeutics, headquartered in Montreal, Quebec, was spun out of venture capital company AmorChem. Source: BioSpace
The company, which now has 11 personnel, is a CRO focused on infectious disease research. Source: BioSpace
The Suzhou-based cancer-drug maker has been discussing a valuation of more than $1 billion. Source: BioSpace
The purpose of the subsidiary is to support the Company’s Japanese clinical and radiopharmaceutical manufacturing activities and to establish a commercial footprint in the Japan, an important market for Telix’s…
Here are three biopharma stocks worth keeping an eye on. Source: BioSpace
The U.S. Food and Drug Administration is set to rule on Tavalisse (fostamatinib disodium), an oral spleen tyrosine kinase (SYK) inhibitor, for adult patients with chronic or persistent immune thrombocytopenia…
Vaccitech is an Oxford University spinout company developing a universal flu vaccine, among other vaccine-related products. Source: BioSpace